USD 5.22 billion
Report ID:
SQMIG15A2297 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
87
|Figures:
72
Contrast Agents Market size was valued at USD 5.36 Billion in 2023 and is poised to grow from USD 5.51 Billion in 2024 to USD 6.82 Billion by 2032, growing at a CAGR of 2.71% during the forecast period (2025-2032).
The rise in complex comorbidities and chronic illnesses has prompted a surge in diagnostic imaging procedures such as ultrasound, X-rays, and advanced technologies such as MRI and CT scans. A significant development occurred in September 2022 with the U.S. FDA's approval of Gadopiclenol, an MRI contrast agent designed with high relativity and a reduced dosage of gadolinium. This approval marks a pivotal step in enhancing imaging precision while prioritizing patient safety, especially for adults and pediatric patients aged two years and above. Gadopiclenol's lower gadolinium dosage aligns with the imperative to minimize potential risks associated with contrast agents, signaling a promising advancement in diagnostic imaging for a diverse range of healthcare needs.
Global Market Size
USD 5.22 billion
Largest Segment
Ultrasound
Fastest Growth
X-ray/CT
Growth Rate
2.71% CAGR
To get more reports on the above market click here to Buy The Report
The global contrast agents market is segmented on the basis of application, product, modality and region. Based on application the market is segmented as, hospitals, clinics. Based on product the market is segmented as iodinated contrast media, microbubble contrast Media. Based on modality the market is segmented as ultrasound, X-ray/CT. Based on region the market is segmented as, North America, Europe, Asia-Pacific,MEA, and Latin America.
Analysis By Modality
The projected trajectory for the ultrasound segment reveals a notable surge in growth within the forecast period, marking it as the fastest-growing domain in medical imaging. This expansion is largely attributed to the development and utilization of contrast agents specifically tailored for ultrasound imaging. These agents cater to visualizing microcirculation within tissues, predominantly relying on microbubbles to augment the echogenicity of blood. This enhancement significantly amplifies the capacity for visualizing and evaluating tissue vascularity, large vessels, and cardiac cavities.
The X-ray/CT segment has emerged as the dominant player, holding a substantial market share of approximately 69.64% in 2023. Central to this segment's effectiveness are the contrast agents specifically designed for X-ray and CT techniques. These agents play a pivotal role in generating high-resolution 3D images of anatomical structures within the body. Barium-based and iodinated contrast media stand out as the primary choices for these imaging procedures. When administered or injected into the body, these contrast agents act by obstructing X-rays, thereby preventing their passage through the targeted tissues.
Analysis By Product
The iodinated contrast media segment emerged as the dominant force, commanding a substantial market share of approximately 65.37% in 2023. This notable position owes much to the widespread utilization of X-ray and CT procedures and the accessibility of nonionic stable iodinated agents, heralding improved diagnostic capabilities. Typically administered intravenously, iodinated contrast media play a crucial role in enhancing the clarity and detail of CT and X-ray images, facilitating more precise diagnoses.
The forecast trajectory for the microbubble contrast media segment indicates a notable surge in growth over the upcoming period. These specialized contrast agents consist of minute bubbles containing an injectable gas, primarily utilized for ultrasound imaging, particularly in cardiac examinations. Their predominant use lies in enhancing the clarity and precision of ultrasound imaging of the heart. Designed specifically for visualizing microcirculation within tissues, microbubble contrast media play a pivotal role in augmenting the echogenicity of blood. This enhancement significantly amplifies the capability to visualize and evaluate tissue vascularity, large vessels, and cardiac cavities.
To get detailed analysis on other segments, Request For Free Sample Report
North America emerged as the predominant force in the market, commanding the largest share, accounting for approximately 36.18%. This stronghold owes much to strategic maneuvers executed by major manufacturers, focusing on specialized patient subsets, poised to drive accelerated growth within the industry. Notable market players such as Bayer, GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics play pivotal roles in shaping this landscape.
The projected highest CAGR in the forecast period is anticipated for the Asia Pacific region, underscoring its potential as a burgeoning market landscape. This growth trajectory finds its roots in the presence of both local and international manufacturers firmly established within the region. General Electric Pharmaceuticals (Shanghai) Co., Ltd., a branch of GE operating in China, stands out as one of the globe's largest contrast media production centers under GE Healthcare.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Rising Demand of Image-Guided Surgeries
Restraints
Side Effects and Allergic Reactions
Request Free Customization of this report to help us to meet your business objectives.
The competitive environment of the global contrast agents market is characterized by a dynamic interplay of key players and evolving strategies within the food processing industry. Innovation is a key competitive factor. smaller and niche players are making a notable impact by focusing on specialized solutions and offering customizable blends to cater to specific meat processing needs. This diversity within the market allows food processors to select tailored solutions that align with their specific requirements.
Top Player’s Company Profiles
Recent Developments
Growing Prevalence of Multiple Chronic Conditions
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global contrast agents market analyses, the increasing growth of the contrast agents market hinges on several key factors, including the surge in chronic disease cases, escalating demand for image-guided diagnostics and procedures, and a notable influx of approvals for contrast agents. Among the pivotal roles of image-guided procedures is their ability to discern the nature of tumors, distinguishing between malignancy and benignity. This crucial distinction significantly impacts treatment pathways and patient outcomes. With the escalating prevalence of cancer cases across both developed and developing economies globally, there exists an imperative to offer procedures that facilitate early-stage diagnosis.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 5.22 billion |
Market size value in 2031 | USD 6.64 billion |
Growth Rate | 2.71% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Contrast Agents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contrast Agents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contrast Agents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Contrast Agents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG15A2297
sales@skyquestt.com
USA +1 351-333-4748